Confirmation of mutations in PROSC as a novel cause of vitamin B 6 -dependent epilepsy
- 8 April 2017
- journal article
- case report
- Published by BMJ in Journal of Medical Genetics
- Vol. 54 (12) , 809-814
Abstract
Vitamin-B6-dependent epilepsies are a heterogenous group of treatable disorders due to mutations in several genes (ALDH7A1, PNPO, ALPL or ALDH4A1). In neonatal seizures, defects in ALDH7A1 and PNPO explain a major fraction of cases. Very recently biallelic mutations in PROSC were shown to be a novel cause in five families. We identified four further unrelated patients harbouring a total of six different mutations, including four novel disease mutations. Vitamin B6 plasma profiles on pyridoxine did not enable the differentiation of patients with PROSC mutations. All four patients were normocephalic and had normal cranial imaging. Pyridoxine monotherapy allowed complete seizure control in one, while two patients had occasional febrile or afebrile seizures and one needed additional valproate therapy for photosensitive seizures. Two patients underwent a controlled pyridoxine withdrawal with signs of encephalopathy within a couple of days. Three had favourable outcome with normal intellectual properties at age 12.5, 15.5 and 30 years, respectively, while one child had marked developmental delay at age 27 months. The clinical and electroencephalographic phenotype in patients with PROSC mutations was indistinguishable from ALDH7A1 and PNPO deficiency. We therefore confirm PROSC as a novel gene for vitamin-B6-dependent epilepsy and delineate a non-specific plasma vitamin B6 profile under pyridoxine treatment.Keywords
Funding Information
- University of Zurich
This publication has 8 references indexed in Scilit:
- Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent EpilepsyThe American Journal of Human Genetics, 2016
- The value of plasma vitamin B6 profiles in early onset epileptic encephalopathiesJournal of Inherited Metabolic Disease, 2016
- Treatable newborn and infant seizures due to inborn errors of metabolismEpileptic Disorders, 2015
- Occasional seizures, epilepsy, and inborn errors of metabolismThe Lancet Neurology, 2014
- Alanine-glyoxylate aminotransferase 2 (AGXT2) Polymorphisms Have Considerable Impact on Methylarginine and β-aminoisobutyrate Metabolism in Healthy VolunteersPLOS ONE, 2014
- Pyridoxal 5'‐phosphate in cerebrospinal fluid; factors affecting concentrationJournal of Inherited Metabolic Disease, 2011
- B6‐responsive disorders: A model of vitamin dependencyJournal of Inherited Metabolic Disease, 2005
- Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.Journal of Clinical Investigation, 1985